Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pancreatic Neoplasms × Tamoxifen × Clear all

Sponsor

Conditions

Breast Neoplasms 58 Carcinoma, Intraductal, Noninfiltrating 6 Breast Neoplasms, Male 5 Neoplasms 3 Neoplasm Metastasis 3 Breast Carcinoma In Situ 3 Urinary Bladder Neoplasms 2 Inflammatory Breast Neoplasms 2 Sleep Wake Disorders 1 Risk Reduction Behavior 1 Obesity 1 Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer 1 Mastodynia 1 Glioma 1 Fibrocystic Breast Disease 1 Fibroadenoma 1 Fatigue 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Disease Progression 1 Desmoid Tumors 1 Cystic Fibrosis 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Lobular 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Cancer Metastatic 1 Brain Neoplasms 1 Arthralgia 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Advanced Metastatic Breast Cancer 1

Interventions

Gemcitabine 141 Fluorouracil 41 Capecitabine 39 130-nm albumin-bound paclitaxel 39 Oxaliplatin 37 Albumin-Bound Paclitaxel 35 Leucovorin 31 Erlotinib Hydrochloride 29 Radiotherapy 20 Irinotecan 20 Bevacizumab 19 pembrolizumab 18 Radiosurgery 16 Docetaxel 16 Cyclophosphamide 15 Taxes 11 Cisplatin 11 Cetuximab 11 folfirinox 9 Nivolumab 9 Ipilimumab 7 Standard of Care 6 Radiation 6 spartalizumab 5 durvalumab 5 dehydroftorafur 5 Surgical Procedures, Operative 5 Paclitaxel 5 Hydroxychloroquine 5 Ascorbic Acid 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡